The fold changes in SELENBP1 expression in tumors against normal tissues of each individual samples are shown in Figure 3C. As compared with matched non-tumor (counterpart normal) liver tissues, levels of SELENBP1 were decreased in 43 HCC cases (71.7%) and were elevated in three cases (3.3%) more than 1.5-fold. The gene discussed is SELENBP1; the disease is hepatocellular carcinoma.